Costanza Di Chiara Selected Research

Costanza Di Chiara Research Topics

12	COVID-19 01/2024 - 01/2021
5	Infections 01/2024 - 01/2022
1	Meningitis 08/2023
1	Peritonitis 08/2023
1	Mediastinitis 08/2023
1	Gram-Positive Bacterial Infections 01/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2022
1	Hemolysis 02/2022
1	Neutropenia 02/2022
1	Malaria 02/2022
1	Falciparum Malaria (Plasmodium falciparum Malaria) 02/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Food Hypersensitivity (Food Allergy) 01/2021

4	Immunoglobulin G (IgG)IBA 01/2024 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 03/2022
2	VaccinesIBA 01/2024 - 08/2023
2	Messenger RNA (mRNA)IBA 12/2023 - 08/2023
2	AntibodiesIBA 12/2023 - 01/2022
2	Monoclonal AntibodiesIBA 10/2023 - 03/2022
2	Neutralizing AntibodiesIBA 01/2021 - 01/2021
1	mRNA VaccinesIBA 12/2023
1	AntigensIBA 12/2023
1	Antiviral Agents (Antivirals)IBA 10/2023
1	Anti-Infective Agents (Microbicides)IBA 08/2023
1	Amoxicillin (Wymox)FDA LinkGeneric 03/2022
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 03/2022
1	Vancomycin FDA LinkGeneric 03/2022
1	Daptomycin FDA Link 03/2022
1	sotrovimabIBA 03/2022
1	ArtesunateIBA 02/2022
1	Filaggrin ProteinsIBA 01/2021

2	Therapeutics 01/2024 - 08/2023
1	Aftercare (After-Treatment) 02/2022